Here’s why Pfizer is revising its revenue forecasts down

by | Dec 16, 2025 | Uncategorized

Spread the love
The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments